Tm Bioscience Corporation - Issuance of Share Purchase
Options
TORONTO, ONTARIO--
Mr. Dave Wales reports:
Subject to approval by the Vancouver Stock Exchange, the Board of
Directors of Tm Bioscience Corporation authorized the issuance of
an aggregate of 1,020,000 share purchase options on May 14, 1998
under the Company's Share Option Plan.
These options were granted to various Tm employees, directors,
senior officers and consultants at an exercise price of $1.00 and
vest in accordance with the provisions of the Share Option Plan.
Including the above option grants, there are currently 4,220,000
shares optioned under the Share Option Plan.
Tm Bioscience Corporation is a biotechnology Company based in
Toronto, Ontario, with a subsidiary Tm Technologies Inc. in
Woburn, Massachusetts. The Company has developed five platform
technologies - biochips, therapeutics, gene expression,
diagnostics and genomic analysis - each of which underlies
multiple commercial products.
-30- |
